Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: GENERAL BIOLOGICS INC
Awarding agency: Department of the Interior / Departmental Offices
Funding agency: Department of Defense / Defense Advanced Research Projects Agency
Period of performance: 2020-02-10 to 2021-07-09
Current total value of award: $225000
Description: DARPA STTR PHASE I - PATTERNED RESPONSIVE CELLULAR THERAPIES